Neglected markers: Altered serum proteome in murine models of disease

Proteomics

Volumn 12, Issue 4-5, 2012, Pages 691-707

  Gianazza, Elisabetta ^a,b   Vegeto, Elisabetta ^b,c   Eberini, Ivano ^a,b   Sensi, Cristina ^a,b   Miller, Ingrid ^d  

^a Gruppo di Studio per la Proteomica e la Struttura delle Proteine   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Centro Dino Ferrari   (Italy)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Acute phase reactant protein; Animal proteomics; Disease specific protein; Species specific protein; Transgenic mice; Transplanted cancer

Indexed keywords

AGGLUTININ; ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA CYANO 4 HYDROXYCINNAMIC ACID; ALPHA FETOPROTEIN; AMYLOID A PROTEIN; APOLIPOPROTEIN; BETA2 GLYCOPROTEIN 1; CATHEPSIN B; CATHEPSIN D; COMPLEMENT FACTOR; CONTRAPSIN; CULLIN; GENTISIC ACID; GLYCOPEPTIDE; HAPTOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; LIPOCALIN; MAJOR URINARY PROTEIN; N ACETYLGLUCOSAMINE; OROSOMUCOID; PLASMINOGEN; PREALBUMIN; PROTEOME; PYRUVATE KINASE; THYROXINE BINDING GLOBULIN; TRACE ELEMENT; TRANSFERRIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL MODEL; ANION EXCHANGE CHROMATOGRAPHY; BINDING AFFINITY; BIOCHEMISTRY; BLOOD CLOTTING; BLOOD LEVEL; CANCER GRAFT; CANCER INVASION; CELL MATURATION; CHROMATOGRAPHY; CIRCADIAN RHYTHM; COLON ADENOMA; CROSSED IMMUNOELECTROPHORESIS; ELECTROPHORETIC MOBILITY; EXPERIMENTAL MOUSE; GEL ELECTROPHORESIS; GENDER; GENE EXPRESSION; HEMOLYSIS; IMMUNE SYSTEM; INSULIN RELEASE; ION EXCHANGE CHROMATOGRAPHY; LYMPHOCYTE; METABOLIC DISORDER; MOUTH CARCINOMA; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN TRANSPORT; PROTEIN URINE LEVEL; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TRANSGENIC ANIMAL; TRANSGENICS; ZONE ELECTROPHORESIS;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PROTEINS; DISEASE MODELS, ANIMAL; MASS SPECTROMETRY; MICE; MICE, TRANSGENIC; NEOPLASMS; PROTEOME; PROTEOMICS;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS;

EID: 84859245804     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100320     Document Type: Review

References (160)

1. Eberini, I., Miller, I., Gemeiner, G., Haynes, P., Aebersold, R. et al., A Web site for the Rat Serum Protein Study Group. Electrophoresis 1999, 20, 3599-3602.
2. Wait, R., Chiesa, G., Parolini, C., Miller, I. et al., Reference maps of mouse serum acute-phase proteins: Changes with LPS-induced inflammation and apolipoprotein A-I and A-II transgenes. Proteomics 2005, 5, 4245-4253.
3. McGregor, R. W., Weselake, R. J., Peltz, B. A., Aoki, F. Y., Friesen, A. D., Partial characterization of α 1-acid glycoprotein isolated from mouse serum. Comp. Biochem. Physiol. B 1987, 86, 493-499.
4. Prowse, K. R., Baumann, H., Hepatocyte-stimulating factor, beta 2 interferon, and interleukin-1 enhance expression of the rat α 1-acid glycoprotein gene via a distal upstream regulatory region. Mol. Cell. Biol. 1988, 8, 42-51.
5. Carter, K. C., Post, D. J., Papaconstantinou, J., Differential expression of the mouse α 1-acid glycoprotein genes (AGP-1 and AGP-2) during inflammation and aging. Biochim. Biophys. Acta 1991, 1089, 197-205.
6. Heegaard, P. M., Changes in serum glycoprotein glycosylation during experimental inflammation in mice are general, unrelated to protein type, and opposite changes in man and rat: studies on mouse serum α 1-acid glycoprotein, α 1-esterase, and α 1-protease inhibitor. Inflammation 1992, 16, 631-644.
7. Kerckaert, J. P., Bayard, B., Biserte, G., Microheterogeneity of rat, mouse and human α1-fetoprotein as revealed by polyacrylamide gel electrophoresis and by crossed immuno-affino-electrophoresis with different lectins. Biochim. Biophys. Acta 1979, 576, 99-108.
8. Hau, J., Chemnitz, J., Teisner, B., Tornehave, D., Svendsen, P., Induction of murine α-foetoprotein synthesis by oestradiol. Acta Endocrinol. 1984, 106, 141-144.
9. Vranckx, R., Savu, L., Maya, M., Nunez, E. A., α-Fetoprotein and transcortin behave as acute phase reactants in the maternal and fetal compartments of the inflammatory pregnant mouse. Endocrinology 1987, 120, 1782-1789.
10. Lamontagne, L., Gauldie, J., Koj, A., Ontogeny and tissue distribution of α-1-antitrypsin of the mouse. Biochim. Biophys. Acta 1981, 662, 15-21.
11. 1-antitrypsin and contrapsin, a novel trypsin inhibitor. J. Biol. Chem. 1982, 257, 2438-2446.
12. 1-antitrypsin against mouse serine proteases. J. Biochem. 1983, 93, 1411-1419.
13. Hill, R. E., Shaw, P. H., Boyd, P. A., Baumann, H., Hastie, N. D., Plasma protease inhibitors in mouse and man: Divergence within the reactive centre regions. Nature 1984, 311, 175-177.
14. 1-antiprotease in the mouse. Biochim. Biophys. Acta 1984, 798, 231-234.
15. Berger, F. G., Baumann, H., An evolutionary switch in tissue-specific gene expression. Abundant expression of α 1-antitrypsin in the kidney of a wild mouse species. J. Biol. Chem. 1985, 260, 1160-1165.
16. 1-protease inhibitor is not an acute phase reactant. Arch. Biochem. Biophys. 1986, 246, 488-493.
17. Nathoo, S. A., Finlay, T. H., Immunological and chemical properties of mouse α 1-protease inhibitors. Arch. Biochem. Biophys. 1986, 246, 162-174.
18. Nathoo, S. A., Finlay, T. H., Fetal-specific forms of α 1-protease inhibitors in mouse plasma. Pediatr. Res. 1987, 22, 1-5.
19. Modha, J., Parikh, V., Gauldie, J., Doenhoff, M. J., An association between schistosomes and contrapsin, a mouse serine protease inhibitor (serpin). Parasitology 1988, 96, 99-109.
20. 1-antiproteinase in inflamed and tumor-bearing mice. Biochem. Int. 1988, 16, 921-928.
21. Koj, A., Rokita, H., Kordula, T., Kurdowska, A., Travis, J., Role of cytokines and growth factors in the induced synthesis of proteinase inhibitors belonging to acute phase proteins. Biomed. Biochim. Acta 1991, 50, 421-425.
22. Schwarzenberg, S. J., Yoon, J. B., Seelig, S., Potter, C. J., Berry, S. A., Discoordinate hormonal and ontogenetic regulation of four rat serpin genes. Am. J. Physiol. 1992, 262, C1144-C1148.
23. Miller, I., Gemeiner, M., Peculiarities in electrophoretic behavior of different serum albumins. Electrophoresis 1993, 14, 1312-1317.
24. MacLaren, I. A., Petras, M. L., Isolation and properties of serum albumin from the house mouse Mus musculus. Biochim. Biophys. Acta 1976, 427, 238-250.
25. Pepys, M. B., Dash, A. C., Fielder, A. H., Mirjah, D. D., Isolation and study of murine C3. Immunology 1977, 33, 491-499.
26. Da Silva, F. P., Hoecker, G. F., Day, N. K., Vienne, K., Rubinstein, P., Murine complement component 3: genetic variation and linkage to H-2. Proc. Natl. Acad. Sci. USA 1978, 75, 963-965.
27. Baba, A., Fujita, T., Tamura, N., Sexual dimorphism of the fifth component of mouse complement. J. Exp. Med. 1984, 160, 411-419.
28. Groen, A., Lagerwerf, A. J., Genetically determined electrophoretic variants of the major urinary protein (Mup) complex in mouse urine. Anim. Blood Groups Biochem. Genet. 1979, 10, 107-114.
29. Hayakawa, J., Nikaido, H., Koizumi, T., Components of major urinary proteins (MUP's) in the mouse. Sex, strain, and subspecies differences. J. Hered. 1983, 74, 453-456.
30. Berger, F. G., Studies on genetic variation in major urinary protein synthesis in mouse liver. Biochem. Genet. 1983, 21, 15-23.
31. Johnson, D., al-Shawi, R., Bishop, J. O., Sexual dimorphism and growth hormone induction of murine pheromone-binding proteins. J. Mol. Endocrinol. 1995, 14, 21-34.
32. Lehman-McKeeman, L. D., Caudill, D., Rodriguez, P. A., Eddy, C., 2-sec-butyl-4, 5-dihydrothiazole is a ligand for mouse urinary protein and rat α 2u-globulin: physiological and toxicological relevance. Toxicol. Appl. Pharmacol. 1998, 149, 32-40.
33. Sharrow, S. D., Vaughn, J. L., Zidek, L., Novotny, M. V., Stone, M. J., Pheromone binding by polymorphic mouse major urinary proteins. Protein Sci. 2002, 11, 2247-2256.
34. Armstrong, S. D., Robertson, D. H., Cheetham, S. A., Hurst, J. L., Beynon, R. J., Structural and functional differences in isoforms of mouse major urinary proteins: a male-specific protein that preferentially binds a male pheromone. Biochem. J. 2005, 391, 343-350.
35. Stopka, P., Janotova, K., Heyrovsky, D., The advertisement role of major urinary proteins in mice. Physiol. Behav. 2007, 91, 667-670.
36. Zhou, Y., Jiang, L., Rui, L., Identification of MUP1 as a regulator for glucose and lipid metabolism in mice. J. Biol. Chem. 2009, 284, 11152-11159.
37. Hui, X., Zhu, W., Wang, Y., Lam, K. S. et al., Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice. J. Biol. Chem. 2009, 284, 14050-14057.
38. Le, P. T., Muller, M. T., Mortensen, R. F., Acute phase reactants of mice. I. Isolation of serum amyloid P-component (SAP) and its induction by a monokine. J. Immunol. 1982, 129, 665-672.
39. Mortensen, R. F., Beisel, K., Zeleznik, N. J., Le, P. T., Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation. J. Immunol. 1983, 130, 885-889.
40. Le, P. T., Mortensen, R. F., In vitro induction of hepatocyte synthesis of the acute phase reactant mouse serum amyloid P-component by macrophages and IL 1. J. Leukoc. Biol. 1984, 35, 587-603.
41. Le, P. T., Mortensen, R. F., Mouse hepatocyte synthesis and induction of the acute phase reactant: serum amyloid P-component. In Vitro 1984, 20, 505-511.
42. Mortensen, R. F., Le, P. T., Taylor, B. A., Mouse serum amyloid P-component (SAP) levels controlled by a locus on chromosome 1. Immunogenetics 1985, 22, 367-375.
43. Sarlo, K. T., Mortensen, R. F., Enhanced interleukin 1 (IL-1) production mediated by mouse serum amyloid P component. Cell Immunol. 1985, 93, 398-405.
44. Bruun, C. F., Sletten, K., Mehlum, A., Marhaug, G., Isolation of serum amyloid A protein by small-scale hydrophobic interaction chromatography and two-dimensional electrophoresis. J. Chromatogr. B Biomed. Appl. 1996, 685, 360-363.
45. Foyn Bruun, C., Sletten, K., Marhaug, G., Mouse serum amyloid A (SAA) proteins isolated by two-dimensional electrophoresis: characterization of isotypes and the effect of separate and combined administrations of cytokines, dexamethasone and lipopolysaccharide (LPS) on serum levels and isotype distribution. Clin. Exp. Immunol. 1998, 111, 231-236.
46. Nybo, M., Hackler, R., Kold, B., Nielsen, E. H. et al., Isoforms of murine and human serum amyloid P component. Scand. J. Immunol. 1998, 48, 350-356.
47. Savu, L., Vranckx, R., Maya, M., Nunez, E. A., A thyroxine binding globulin (TBG)-like protein in the sera of developing and adult rats. Biochem. Biophys. Res. Commun. 1987, 148, 1165-1173.
48. Savu, L., Vranckx, R., Maya, M., Gripois, D. et al., Thyroxine-binding globulin and thyroxine-binding prealbumin in hypothyroid and hyperthyroid developing rats. Biochim. Biophys. Acta 1989, 992, 379-384.
49. Savu, L., Vranckx, R., Maya, M., Nunez, E. A., Binding activities of thyroxine binding globulin versus thyroxine binding prealbumin in rat sera: differential modulation of thyroid hormone ligands, oleic acid and pharmacological drugs. Biochem. Biophys. Res. Commun. 1989, 159, 919-926.
50. Vranckx, R., Rouaze, M., Savu, L., Nunez, E. A. et al., The hepatic biosynthesis of rat thyroxine binding globulin (TBG): demonstration, ontogenesis, and up-regulation in experimental hypothyroidism. Biochem. Biophys. Res. Commun. 1990, 167, 317-322.
51. Vranckx, R., Savu, L., Maya, M., Nunez, E. A., Characterization of a major development-regulated serum thyroxine-binding globulin in the euthyroid mouse. Biochem. J. 1990, 271, 373-379.
52. Vranckx, R., Savu, L., Maya, M., Rouaze-Romet, M., Nunez, E. A., Immunological quantitation of rat and mouse thyroxine-binding globulins. Ontogenesis and sex-dependence of the circulating levels of the thyroxine-binding globulins. Acta Endocrinol. 1990, 123, 649-656.
53. Savu, L., Vranckx, R., Rouaze-Romet, M., Maya, M. et al., A senescence up-regulated protein: The rat thyroxine-binding globulin (TBG). Biochim. Biophys. Acta 1991, 1097, 19-22.
54. Vranckx, R., Savu, L., Lambert, N., de Conchard, G. V. et al., Plasma proteins as biomarkers of the aging process. Am. J. Physiol. 1995, 268, R536-R548.
55. Crowle, A. J., Miller, J. L., Crossed immunoelectrophoresis of mouse serum. J. Immunol. Methods 1981, 43, 15-28.
56. Miller, J. L., Crowle, A. J., Crossed immunoelectrophoresis of neonatal and juvenile mouse serum. Proc. Soc. Exp. Biol. Med. 1982, 169, 27-35.
57. Arakawa, H., Blanchard, D. C., Arakawa, K., Dunlap, C., Blanchard, R. J., Scent marking behavior as an odorant communication in mice. Neurosci. Biobehav. Rev. 2008, 32, 1236-1248.
58. Bendixen, E., Danielsen, M., Hollung, K., Gianazza, E., Miller, I., Farm animal proteomics - a review. J. Proteomics 2011, 74, 282-293.
59. Zaias, J., Mineau, M., Cray, C., Yoon, D., Altman, N. H., Reference values for serum proteins of common laboratory rodent strains. J. Am. Assoc. Lab. Anim. Sci. 2009, 48, 387-390.
60. Cray, C., Rodriguez, M., Zaias, J., Altman, N. H., Effects of storage temperature and time on clinical biochemical parameters from rat serum. J. Am. Assoc. Lab. Anim. Sci. 2009, 48, 202-204.
61. Crivellente, F., Bonato, M., Cristofori, P., Analysis of mouse, rat, dog, marmoset, and human serum proteins by capillary electrophoresis: comparison with agarose gel electrophoresis. Vet. Clin. Pathol. 2008, 37, 73-78.
62. Wait, R., Begum, S., Brambilla, D., Carabelli, A. M. et al., Redox options in two-dimensional electrophoresis. Amino Acids 2005, 28, 239-272.
63. Ritorto, M. S., Borlak, J., A simple and reliable protocol for mouse serum proteome profiling studies by use of two-dimensional electrophoresis and MALDI TOF/TOF mass spectrometry. Proteome Sci. 2008, 6, 25.
64. Chen, Y. Y., Lin, S. Y., Yeh, Y. Y., Hsiao, H. H. et al., A modified protein precipitation procedure for efficient removal of albumin from serum. Electrophoresis 2005, 26, 2117-2127.
65. Duan, X., Yarmush, D., Berthiaume, F., Jayaraman, A., Yarmush, M. L., Immunodepletion of albumin for two-dimensional gel detection of new mouse acute-phase protein and other plasma proteins. Proteomics 2005, 5, 3991-4000.
66. Zhou, J. Y., Petritis, B. O., Petritis, K., Norbeck, A. D. et al., Mouse-specific tandem IgY7-SuperMix immunoaffinity separations for improved LC-MS/MS coverage of the plasma proteome. J. Proteome Res. 2009, 8, 5387-5395.
67. Leatherbarrow, R. J., Dean, P. D., Studies on the mechanism of binding of serum albumins to immobilized cibacron blue F3GA. Biochem. J. 1980, 189, 27-34.
68. Naval, J., Calvo, M., Lampreave, F., Piñeiro, A., Interactions of different albumins and animal sera with insolubilized Cibacron Blue: evaluation of apparent affinity constants. Comp. Biochem. Physiol. B. 1982, 71, 403-407.
69. Miller, I., Gemeiner, M., An electrophoretic study on interactions of albumins of different species with immobilized Cibacron Blue F3G A. Electrophoresis 1998, 19, 2506-2514.
70. Hood, B. L., Zhou, M., Chan, K. C., Lucas, D. A. et al., Investigation of the mouse serum proteome. J. Proteome Res. 2005, 4, 1561-1568.
71. Lai, K. K., Kolippakkam, D., Beretta, L., Comprehensive and quantitative proteome profiling of the mouse liver and plasma. Hepatology 2008, 47, 1043-1051.
72. Florian, M., Cera, L., Duff, R., Maddineni, J. et al., Comparative ProteinChip array profiling of human, non-human primate, pig, dog, rabbit, rat, and mice plasma using surface enhanced laser desorption ionization (SELDI) method. FASEB J. 2006, 20, A1104.
73. Grunert, T., Marchetti-Deschmann, M., Miller, I., Muller, M., Allmaier, G., Comparing the applicability of CGE-on-the-chip and SDS-PAGE for fast pre-screening of mouse serum samples prior to proteomics analysis. Electrophoresis 2008, 29, 4332-4340.
74. Zhang, H., Yi, E. C., Li, X. J., Mallick, P. et al., High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol. Cell. Proteomics 2005, 4, 144-155.
75. Bernhard, O. K., Kapp, E. A., Simpson, R. J., Enhanced analysis of the mouse plasma proteome using cysteine-containing tryptic glycopeptides. J. Proteome Res. 2007, 6, 987-995.
76. Whiteaker, J. R., Zhang, H., Zhao, L., Wang, P. et al., Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. J. Proteome Res. 2007, 6, 3962-3975.
77. Cray, C., Zaias, J., Altman, N. H., Acute phase response in animals: a review. Comp. Med. 2009, 59, 517-526.
78. Quintero, S., Crowle, A. J., Anaphylaxis in the mouse - a model for using two-dimensional electroimmunodiffusion to study pathological changes in multiple serum proteins simultaneously. Clin. Chem. 1979, 25, 723-728.
79. Baumann, H., Berger, F. G., Genetics and evolution of the acute phase proteins in mice. Mol. Gen. Genet. 1985, 201, 505-512.
80. Glibetic, M. D., Baumann, H., Influence of chronic inflammation on the level of mRNA for acute-phase reactants in the mouse liver. J. Immunol. 1986, 137, 1616-1622.
81. Khovidhunkit, W., Duchateau, P. N., Medzihradszky, K. F., Moser, A. H. et al., Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. Atherosclerosis 2004, 176, 37-44.
82. Duan, X., Yarmush, D. M., Berthiaume, F., Jayaraman, A., Yarmush, M. L., A mouse serum two-dimensional gel map: application to profiling burn injury and infection. Electrophoresis 2004, 25, 3055-3065.
83. Roemer, I., Vogel, T., Otto, A., Fichtner, I., Klose, J., Analysis of mouse b-haptoglobin chain by lectin affinoblotting detection. Electrophoresis 2001, 22, 3038-3042.
84. Brewis, I. A., Brennan, P., Proteomics technologies for the global identification and quantification of proteins. Adv. Protein Chem. Struct. Biol. 2010, 80, 1-44.
85. Rantalainen, M., Cloarec, O., Beckonert, O., Wilson, I. D. et al., Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice. J. Proteome Res. 2006, 5, 2642-2655.
86. Bhat, V. B., Choi, M. H., Wishnok, J. S., Tannenbaum, S. R., Comparative plasma proteome analysis of lymphoma-bearing SJL mice. J. Proteome Res. 2005, 4, 1814-1825.
87. Kristiansson, M. H., Bhat, V. B., Babu, I. R., Wishnok, J. S., Tannenbaum, S. R., Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice. J. Proteome Res. 2007, 6, 1735-1744.
88. Hood, B. L., Lucas, D. A., Kim, G., Chan, K. C. et al., Quantitative analysis of the low molecular weight serum proteome using 18O stable isotope labeling in a lung tumor xenograft mouse model. J. Am. Soc. Mass Spectrom. 2005, 16, 1221-1230.
89. Kurogochi, M., Matsushista, T., Amano, M., Furukawa, J. et al., Sialic acid-focused quantitative mouse serum glycoproteomics by multiple reaction monitoring assay. Mol. Cell. Proteomics, 2010, 9, 2354-2368.
90. von Toerne, C., Becker, S., Kahle, M., Neschen, S. et al., "Proteomic Forum 2011", Berlin 2011.
91. Rangiah, K., Tippornwong, M., Sangar, V., Austin, D. et al., Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer. J. Proteome Res. 2009, 8, 5153-5164.
92. Martino, T. A., Tata, N., Bjarnason, G. A., Straume, M., Sole, M. J., Diurnal protein expression in blood revealed by high throughput mass spectrometry proteomics and implications for translational medicine and body time of day. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293, R1430-R1437.
93. Refinetti, R., Circadian Physiology, CRC Press, Boca Raton 2006.
94. Crowle, A. J., Miller, J. L., Crossed immunoelectrophoresis of sera from adult through aged mice. Proc. Soc. Exp. Biol. Med. 1982, 169, 19-26.
95. Ding, J., Kopchick, J. J., Plasma biomarkers of mouse aging. Age (Dordr) 2010, 33, 291-307.
96. Espinosa, E., Canelo, E., Bravo, M., Gonzalez, O., Sex-associated differences in serum proteins of mice. Science 1964, 144, 417-418.
97. Waites, G. T., Bell, A. M., Bell, S. C., Acute phase serum proteins in syngeneic and allogeneic mouse pregnancy. Clin. Exp. Immunol. 1983, 53, 225-232.
98. Waites, G. T., Bell, S. C., Identification of a murine pregnancy-associated serum protein (α 1-PAP) a female-specific acute-phase reactant. J. Reprod. Fertil. 1984, 70, 581-589.
99. Aoi, W., Takanami, Y., Kawai, Y., Morifuji, M. et al., Dietary whey hydrolysate with exercise alters the plasma protein profile: a comprehensive protein analysis. Nutrition 2011, 27, 687-692.
100. Cervi, D., Pak, B., Venier, N. A., Sugar, L. M. et al., Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4. BMC Cancer 2010, 10, 258.
101. Hung, K. E., Kho, A. T., Sarracino, D., Richard, L. G. et al., Mass spectrometry-based study of the plasma proteome in a mouse intestinal tumor model. J. Proteome Res. 2006, 5, 1866-1878.
102. Hung, K. E., Faca, V., Song, K., Sarracino, D. A. et al., Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis. Cancer Prev. Res. (Phila) 2009, 2, 224-233.
103. Schorpp, M., Hofmann, M., Dear, T. N., Boehm, T., Characterization of mouse and human nude genes. Immunogenetics 1997, 46, 509-515.
104. Shinkai, Y., Rathbun, G., Lam, K. P., Oltz, E. M. et al., RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68, 855-867.
105. Xiang, Y., Ma, B., Yu, H. M., Li, X. J., The protein profile of acetazolamide-treated sera in mice bearing Lewis neoplasm. Life Sci. 2004, 75, 1277-1285.
106. Juan, H. F., Chen, J. H., Hsu, W. T., Huang, S. C. et al., Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human. Proteomics 2004, 4, 2766-2775.
107. Sandoval, J. A., Turner, K. E., Hoelz, D. J., Rescorla, F. J. et al., Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers. J. Surg. Res. 2007, 142, 268-274.
108. Bijian, K., Mlynarek, A. M., Balys, R. L., Jie, S. et al., Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment. J. Proteome Res. 2009, 8, 2173-2185.
109. Huang, X., Wei, Y., Li, L., Wen, Y. et al., Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. Oral Oncol. 2006, 42, 26-31.
110. Petrak, J., Ivanek, R., Toman, O., Cmejla, R. et al., Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 2008, 8, 1744-1749.
111. Wang, P., Bouwman, F. G., Mariman, E. C., Generally detected proteins in comparative proteomics - a matter of cellular stress response? Proteomics 2009, 9, 2955-2966.
112. Tammen, H., Schorn, K., Selle, H., Hess, R. et al., Identification of peptide tumor markers in a tumor graft model in immunodeficient mice. Comb. Chem. High Throughput Screen. 2005, 8, 783-788.
113. Pousset, D., Piller, V., Bureaud, N., Piller, F., High levels of ceruloplasmin in the serum of transgenic mice developing hepatocellular carcinoma. Eur. J. Biochem. 2001, 268, 1491-1499.
114. Gazzana, G., Borlak, J., Mapping of the serum proteome of hepatocellular carcinoma induced by targeted overexpression of epidermal growth factor to liver cells of transgenic mice. J. Proteome Res. 2008, 7, 928-937.
115. Chatterji, B., Borlak, J., Serum proteomics of lung adenocarcinomas induced by targeted overexpression of c-raf in alveolar epithelium identifies candidate biomarkers. Proteomics 2007, 7, 3980-3991.
116. Chatterji, B., Borlak, J., A 2-DE MALDI-TOF study to identify disease regulated serum proteins in lung cancer of c-myc transgenic mice. Proteomics 2009, 9, 1044-1056.
117. Pitteri, S. J., Faca, V. M., Kelly-Spratt, K. S., Kasarda, A. E. et al., Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells. J. Proteome Res. 2008, 7, 1481-1489.
118. Faca, V. M., Song, K. S., Wang, H., Zhang, Q. et al., A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med. 2008, 5, e123.
119. Pitteri, S. J., JeBailey, L., Faca, V. M., Thorpe, J. D. et al., Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS One 2009, 4, e7916.
120. Menon, R., Zhang, Q., Zhang, Y., Fermin, D. et al., Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer. Cancer Res. 2009, 69, 300-309.
121. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
122. Altland, K., Roeder, T., Jakin, H. M., Zimmer, H. G., Neuhoff, V., Demonstration of α 1-acid glycoprotein (orosomucoid) by double one-dimensional slab gel electrophoresis: evidence for intra- and interindividual variability of the microheterogeneity pattern in health and disease. Clin. Chem. 1982, 28, 1000-1010.
123. Shiyan, S. D., Bovin, N. V., Carbohydrate composition and immunomodulatory activity of different glycoforms of α1-acid glycoprotein. Glycoconj. J. 1997, 14, 631-638.
124. Hashimoto, S., Asao, T., Takahashi, J., Yagihashi, Y. et al., α1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis. Cancer 2004, 101, 2825-2836.
125. de Jong, G., van Eijk, H. G., Microheterogeneity of human serum transferrin: A biological phenomenon studied by isoelectric focusing in immobilized pH gradients. Electrophoresis 1988, 9, 589-598.
126. Yamashita, K., Koide, N., Endo, T., Iwaki, Y., Kobata, A., Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J. Biol. Chem. 1989, 264, 2415-2423.
127. de Jong, G., van Noort, W. L., Feelders, R. A., de Jeu-Jaspars, C. M., van Eijk, H. G., Adaptation of transferrin protein and glycan synthesis. Clin. Chim. Acta 1992, 212, 27-45.
128. Alm, R., Eriksson, S., Biosynthesis of abnormally glycosylated hepatoma secretory proteins in cell cultures. FEBS Lett. 1985, 190, 157-160.
129. Kirmiz, C., Li, B., An, H. J., Clowers, B. H. et al., A serum glycomics approach to breast cancer biomarkers. Mol. Cell. Proteomics 2007, 6, 43-55.
130. Lin, S. Y., Chen, Y. Y., Fan, Y. Y., Lin, C. W. et al., Precise mapping of increased sialylation pattern and the expression of acute phase proteins accompanying murine tumor progression in BALB/c mouse by integrated sera proteomics and glycomics. J. Proteome Res. 2008, 7, 3293-3303.
131. Rees, D. A., Alcolado, J. C., Animal models of diabetes mellitus. Diabet Med. 2005, 22, 359-370.
132. Szkudelski, T., The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 2001, 50, 537-546.
133. Vassilopoulos, S., Esk, C., Hoshino, S., Funke, B. H. et al., A role for the CHC22 clathrin heavy-chain isoform in human glucose metabolism. Science 2009, 324, 1192-1196.
134. Diao, W. F., Chen, W. Q., Wu, Y., Liu, P. et al., Serum, liver, and kidney proteomic analysis for the alloxan-induced type I diabetic mice after insulin gene transfer of naked plasmid through electroporation. Proteomics 2006, 6, 5837-5845.
135. Okada, S., List, E. O., Sankaran, S., Kopchick, J. J., Plasma protein biomarkers correlated with the development of diet-induced type 2 diabetes in mice. Clin. Proteomics 2010, 6, 6-17.
136. Kim, S. W., Hwang, H. J., Baek, Y. M., Hwang, H. S., Yun, J. W., Proteomic analysis in ob/ob mice before and after hypoglycemic polysaccharide treatments. J. Microbiol. Biotechnol. 2009, 19, 1109-1121.
137. Kumar, S. G., Rahman, M. A., Lee, S. H., Hwang, H. S. et al., Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Proteomics 2009, 9, 2149-2162.
138. Camus, M. C., Chapman, M. J., Forgez, P., Laplaud, P. M., Distribution and characterization of the serum lipoproteins and apoproteins in the mouse, Mus musculus. J. Lipid Res. 1983, 24, 1210-1228.
139. Hajri, T., Elliott-Bryant, R., Sipe, J. D., Liang, J. S. et al., The acute phase response in apolipoprotein A-1 knockout mice: apolipoprotein serum amyloid A and lipid distribution in plasma high density lipoproteins. Biochim. Biophys. Acta 1998, 1394, 209-218.
140. Lutgens, E., Faber, B., Schapira, K., Evelo, C. T. et al., Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: Validation using a novel monocyte chemoattractant protein monoclonal antibody. Circulation 2005, 111, 3443-3452.
141. Schneider, J. G., Zhu, Y., Coleman, T., Semenkovich, C. F., Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFα expression. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 2699-2706.
142. Nunemaker, C. S., Chen, M., Pei, H., Kimble, S. D. et al., 12-Lipoxygenase-knockout mice are resistant to inflammatory effects of obesity induced by Western diet. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E1065-E1075.
143. Tikellis, C., Thomas, M. C., Harcourt, B. E., Coughlan, M. T. et al., Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E323-330.
144. Cole, B. K., Keller, S. R., Wu, R., Carter, J. D. et al., Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice. Hypertension 2010, 55, 715-721.
145. Wan, J. B., Huang, L. L., Rong, R., Tan, R. et al., Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 2487-2494.
146. Igl, W., Johansson, A., Wilson, J. F., Wild, S. H. et al., Modeling of environmental effects in genome-wide association studies identifies SLC2A2 and HP as novel loci influencing serum cholesterol levels. PLoS Genet. 2010, 6, e1000798.
147. Tabibiazar, R., Wagner, R. A., Deng, A., Tsao, P. S., Quertermous, T., Proteomic profiles of serum inflammatory markers accurately predict atherosclerosis in mice. Physiol. Genomics 2006, 25, 194-202.
148. Eberini, I., Agnello, D., Miller, I., Villa, P. et al., Proteins of rat serum: V. Adjuvant arthritis and its modulation by non steroidal antiinflammatory drugs. Electrophoresis 2000, 21, 2170-2179.
149. Poon, S., Easterbrook-Smith, S. B., Rybchyn, M. S., Carver, J. A., Wilson, M. R., Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. Biochemistry 2000, 39, 15953-15960.
150. Yerbury, J. J., Rybchyn, M. S., Easterbrook-Smith, S. B., Henriques, C., Wilson, M. R., The acute phase protein haptoglobin is a mammalian extracellular chaperone with an action similar to clusterin. Biochemistry 2005, 44, 10914-10925.
151. Devaraj, S., Singh, U., Jialal, I., The evolving role of C-reactive protein in atherothrombosis. Clin. Chem. 2009, 55, 229-238.
152. Consortium, M. G. S., Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420, 520-562.
153. Wait, R., Miller, I., Eberini, I., Cairoli, F. et al., Strategies for proteomics with incompletely characterised genomes: the proteome of Bos taurus serum. Electrophoresis 2002, 23, 3418-3427.
154. Sun, B., Zhang, S., Zhang, D., Liu, Y. et al., Clusterin is associated with spontaneous breast cancer in TA2 mice. FEBS Lett. 2007, 581, 3277-3282.
155. Poste, G., Bring on the biomarkers. Nature 2011, 469, 156-157.
156. Gianazza, E., Eberini, I., Sensi, C., Barile, M. et al., Energy matters: mitochondrial proteomics for biomedicine. Proteomics 2011, 11, 657-674.
157. Ponten, F., Gry, M., Fagerberg, L., Lundberg, E. et al., A global view of protein expression in human cells, tissues, and organs. Mol. Syst. Biol. 2009, 5, 337.
158. Gry, M., Oksvold, P., Pontén, F., Uhlén, M., Tissue-specific protein expression in human cells, tissues and organs. J. Proteomics Bioinform. 2010, 3, 286-293.
159. Gianazza, E., Giacon, P., Sahlin, B., Righetti, P. G., Non-linear pH courses with immobilized pH gradients. Electrophoresis 1985, 6, 53-56.
160. Gianazza, E., Guerini Rocco, A., Marchetto, A., Vergani, L., Immobilized pH gradients with electrodic plateaus (and other unusual procedures for 2DE). Electrophoresis 2007, 28, 2953-2956.